Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1982 5
1984 5
1985 30
1986 42
1987 15
1988 50
1989 25
1990 19
1991 38
1992 30
1993 18
1994 14
1995 18
1996 13
1997 15
1998 17
1999 18
2000 15
2001 12
2002 9
2003 8
2004 11
2005 7
2006 10
2007 9
2008 7
2009 3
2010 8
2011 4
2012 8
2013 6
2014 8
2015 2
2016 4
2017 5
2018 3
2019 3
2020 7
2021 9
2022 9
2023 8
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

536 results

Results by year

Filters applied: . Clear all
Page 1
Celiprolol.
Dickinson R, Horobin J. Dickinson R, et al. Lancet. 1992 Apr 11;339(8798):940. doi: 10.1016/0140-6736(92)90990-k. Lancet. 1992. PMID: 1348344 No abstract available.
Celiprolol.
Thom S, Hughes A, Schachter M, Sever P. Thom S, et al. Lancet. 1992 Jan 25;339(8787):247. doi: 10.1016/0140-6736(92)90051-4. Lancet. 1992. PMID: 1346201 No abstract available.
Characterization of degradation products of celiprolol hydrochloride using hyphenated mass and NMR techniques.
Sahu A, Balhara A, Raju N, Kumar BK, Sharma P, Singh DK, Singh S. Sahu A, et al. J Pharm Biomed Anal. 2021 Apr 15;197:113953. doi: 10.1016/j.jpba.2021.113953. Epub 2021 Feb 8. J Pharm Biomed Anal. 2021. PMID: 33618130
Stress degradation studies were carried out on celiprolol hydrochloride under the ICH prescribed hydrolysis (acidic, basic and neutral), photolytic, oxidative and thermal conditions. ...
Stress degradation studies were carried out on celiprolol hydrochloride under the ICH prescribed hydrolysis (acidic, basic and …
An old drug for a rare disease: The example of celiprolol for vascular Ehlers-Danlos syndrome.
Boutouyrie P. Boutouyrie P. Therapie. 2020 Apr;75(2):175-181. doi: 10.1016/j.therap.2020.02.009. Epub 2020 Feb 13. Therapie. 2020. PMID: 32127191 Review. French.
This effect was similar in molecular-proven patients. Administration of celiprolol in a cohort of patients followed routinely in France was accompanied to similar benefit. Celiprolol is unavailable in the USA. The ACER Therapeutics company applied for new drug appli …
This effect was similar in molecular-proven patients. Administration of celiprolol in a cohort of patients followed routinely in Fran …
Celiprolol and sympatho-immune interface in COVID-19.
Al-Kuraishy HM, Albuhadily AK, Al-Gareeb AI, El-Bouseary MM, Alexiou A, Papadakis M, Batiha GE. Al-Kuraishy HM, et al. Immunology. 2023 Dec;170(4):579-582. doi: 10.1111/imm.13693. Epub 2023 Sep 7. Immunology. 2023. PMID: 37679864 No abstract available.
Celiprolol in hypertension.
Taylor SH. Taylor SH. Am Heart J. 1988 Nov;116(5 Pt 2):1426-34. doi: 10.1016/0002-8703(88)90135-4. Am Heart J. 1988. PMID: 2903654 Review.
Celiprolol is a third-generation, beta-adrenoceptor antagonist with ancillary pharmacologic properties that are potentially advantageous in the treatment of hypertension. ...Therefore the primary attributes of beta-blockade are uniquely advanced by celiprolol's anci …
Celiprolol is a third-generation, beta-adrenoceptor antagonist with ancillary pharmacologic properties that are potentially advantage …
Celiprolol: introduction.
Gorlin R. Gorlin R. Am Heart J. 1988 Nov;116(5 Pt 2):1383-4. doi: 10.1016/0002-8703(88)90127-5. Am Heart J. 1988. PMID: 2903646 No abstract available.
Improvement in Quality of Life Following Celiprolol Hydrochloride Administration in a Patient with Vascular Ehlers-Danlos Syndrome: A Case Report.
Shimizu K, Kameoka Y, Motohashi K, Munetomo Y, Kurata N, Sadaoka S. Shimizu K, et al. Ann Vasc Dis. 2023 Jun 25;16(2):146-149. doi: 10.3400/avd.cr.22-00130. Ann Vasc Dis. 2023. PMID: 37359101 Free PMC article.
She experienced chronic anemia for many years due to the easy bruising of her whole body. The bruising improved with oral administration of celiprolol hydrochloride. There were no cardiac or vascular events during the 7 years following the transcatheter arterial emb …
She experienced chronic anemia for many years due to the easy bruising of her whole body. The bruising improved with oral administration of …
Pharmacology of celiprolol.
Louis WJ, Drummer OH, Tung LH. Louis WJ, et al. Cardiovasc Drugs Ther. 1991 Jan;4 Suppl 6:1281-5. doi: 10.1007/BF00114234. Cardiovasc Drugs Ther. 1991. PMID: 1672604
The pharmacology of celiprolol and its relationship to some other beta-adrenoceptor antagonists is described. ...In the pithed rat, celiprolol's ISA was demonstrated at much lower doses than for pindolol, even though pindolol has a similar potency to celiprolol …
The pharmacology of celiprolol and its relationship to some other beta-adrenoceptor antagonists is described. ...In the pithed rat, …
Safety profile of celiprolol.
Lamon KD. Lamon KD. Am Heart J. 1988 Nov;116(5 Pt 2):1438-40. doi: 10.1016/0002-8703(88)90138-x. Am Heart J. 1988. PMID: 2903657 Review.
Celiprolol hydrochloride is a highly cardioselective beta1-adrenergic antagonist with a unique pharmacologic profile. ...Celiprolol exhibited an adverse experience profile similar to that of placebo and resulted in a lower incidence of bradycardia and age-ass …
Celiprolol hydrochloride is a highly cardioselective beta1-adrenergic antagonist with a unique pharmacologic profile. ...Ce …
536 results